Topic: Drug-delivery

Could treating diabetes someday be as simple as slapping on a patch? A UCLA-led research […]

Dive Brief: FDA reported Friday that certain infusion pump systems recalled by BD on Feb. 4 […]

Dive Brief: Insulet is pausing the clinical trial it hoped would support commercialization of its […]

Progress on new pump hardware, a wider age indication for its new insulin dosing algorithm, […]

Remunity™ expected to be available for patients by July 2020 RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. […]

Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor […]

Integer Holdings (NYSE:ITGR) today announced it has acquired medtech manufacturer Inomec, formally establishing its presence […]

Dive Brief: Continuous glucose monitor market giants Dexcom and Abbott on Wednesday independently announced plans […]

BIOTRONIK won the European CE Mark for its Orsiro Mission drug-eluting stent. The device is […]

Senseonics (NYSE:SENS) will integrate its Eversense continuous glucose monitoring (CGM) system’s real-time glucose data with Companion Medical‘s InPen […]

Tension over stents and balloons that are either coated with or are designed to release paclitaxel […]

New technology has been making an impact on how diabetics control their blood sugar levels. […]

Contura announced that it won FDA premarket approval for its Bulkamid hydrogel injection for treating stress […]

Rani Therapeutics is reportedly moving forward with an early-stage efficacy and safety study for its […]

A Boston Scientific (NYSE:BSX) device coated with less of the controversial drug paclitaxel than one […]

Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million […]

Lantheus today said it appointed Paul Blanchfield as chief commercial officer, effective immediately. Blanchfield will […]

Smith & Nephew (NYSE:SNN) today said it acquired Tusker Medical for an undisclosed amount. Tusker Medical […]

Bigfoot Biomedical, a diabetes startup looking to automate insulin delivery via a connected insulin pen, […]

Bigfoot Biomedical Inc. has picked up some ammunition as it moves closer to commercializing its […]

It may only be January, but it looks like 2020 could be Bigfoot Biomedical’s year. […]

TriSalus this week launched its TriNac Infusion System. The infusion system is powered by the company’s […]

Medtech and pharmaceutical companies have made several important strides over the past year when it […]

Dive Brief: Peripheral arterial occlusive disease patients treated with a paclitaxel-coated device for chronic limb […]

Phillips-Medisize, a Molex company,  announced today that it has expanded its Global Innovation and Development […]

CHICAGO and PLEASANTON, Calif., Jan. 8, 2020 /PRNewswire/ — Vyaire Medical, Inc. and Spirosure, Inc. have entered a five-year agreement […]

Transdermal drug therapy developer Dyve Biosciences announced that it appointed longtime Pfizer executive Chuck Harbert to the […]

The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute […]

Dive Brief: Analysts at Baird Equity Research predict continued strong adoption of insulin pumps and […]

Faced with growing competition in the market for diabetes devices, Tandem Diabetes Care’s stock shot […]

The FDA is seeking comment from sponsors of combination products on how they want the […]

Dive Brief: FDA is seeking feedback on how it communicates with developers of combination products. […]

Teleflex  (NYSE:TFX) today issued a safety warning in the United Kingdom for its Arrow EZ-IO […]

BETHLEHEM, Pa., Dec. 16, 2019 /PRNewswire/ — B. Braun Medical Inc. (B. Braun) today announced the appointment of Jean-Claude […]

Eli Lilly (NYSE:LLY) announced that it will integrate Dexcom (NSDQ:DXCM) products into its personalized diabetes management system, […]

The FDA announced Friday a De Novo clearance for an interoperable automated glycemic controller device […]

Dive Brief: FDA on Friday authorized the third and final type of diabetes management technology […]

  The FDA today gave De Novo authorization for a Tandem Diabetes Care (NSDQ:TNDM) glycemic controller […]

3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery […]